These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15365009)

  • 21. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
    Selabe SG; Song E; Burnett RJ; Mphahlele MJ
    J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
    Pan XP; Wo JE; Chen Z; Chen F; Liang WF; Liu KZ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
    Shi M; Yang ZJ; Wang RS; Zhang H; Zhu YF; Xu YP; Lin QY; Jin LJ
    Clin Chim Acta; 2006 Nov; 373(1-2):172-5. PubMed ID: 16814763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction and application of a genechip method for detection of hepatitis B virus lamivudine-resistant mutants and basal core promotor/Pre-C mutants].
    Li B; Zhou BP; Peng JF; Chen LY; Zhang W; Tang W; Wang ZQ; Yin ZH; Xu LM; Luo RL; Li XH; Liu SY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):309-12. PubMed ID: 20108783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F; Akuta N; Suzuki Y; Sezaki H; Arase Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Watahiki S; Kumada H
    J Med Virol; 2006 Mar; 78(3):341-52. PubMed ID: 16419116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients.
    Zhao W; Wan JM; Liu W; Liu QJ; Zhang L; Zhou ZX; Liu XJ; Zhang HR
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):234-41. PubMed ID: 14599976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
    Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene].
    Ding JJ; Zhang WS; Zhang LS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):24-7. PubMed ID: 15340520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
    Huang XT; Zeng AP; Lin F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):185-7. PubMed ID: 17653332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].
    Hu YY; Jiang JJ; Li D; Lin CW; Li QG; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):427-30. PubMed ID: 12890350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.
    Ben-Ari Z; Daudi N; Klein A; Sulkes J; Papo O; Mor E; Samra Z; Gadba R; Shouval D; Tur-Kaspa R
    Am J Gastroenterol; 2003 Jan; 98(1):151-9. PubMed ID: 12526951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of oligonucleotide microarray on monitoring the lamivudine-resistance mutations in hepatitis B virus].
    Song JW; Lin JS; Kong XJ; Liang KH
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):361-3. PubMed ID: 12837218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
    Tadokoro K; Suzuki F; Kobayashi M; Yamaguchi T; Nagano M; Egashira T; Kumada H
    J Virol Methods; 2011 Jan; 171(1):67-73. PubMed ID: 20950650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR.
    Punia P; Cane P; Teo CG; Saunders N
    J Hepatol; 2004 Jun; 40(6):986-92. PubMed ID: 15158340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
    Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
    Feng B; Wei L; Chen M; Wang L
    Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
    Chan HL; Chui AK; Lau WY; Chan FK; Hui AY; Rao AR; Wong J; Lai EC; Sung JJ
    Clin Transplant; 2004 Jun; 18(3):295-300. PubMed ID: 15142051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.